Skip to main content

Peer Review reports

From: Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study

Original Submission
13 Sep 2022 Submitted Original manuscript
30 Sep 2022 Reviewed Reviewer Report - Eleonora De Matteis
2 Oct 2022 Reviewed Reviewer Report - Antonio Russo
11 Oct 2022 Reviewed Reviewer Report
18 Oct 2022 Author responded Author comments - Uwe Reuter
Resubmission - Version 2
18 Oct 2022 Submitted Manuscript version 2
Publishing
19 Oct 2022 Editorially accepted
15 Nov 2022 Article published 10.1186/s10194-022-01511-y

You can find further information about peer review here.

Back to article page